Toshihiko Kawamura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Toshihiko Kawamura has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Toru Abo
Divisions of Immunology and Medical Zoology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
2 shared publications- Hiroki Kawamura
Division of Immunology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
1 shared publication Kazuyoshi Takeda
Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan
1 shared publicationKo Okumura
Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan
1 shared publication- Luc Van Kaer
Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA
1 shared publication Takahiro Kobayashi
Divisions of Immunology and Medical Zoology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
1 shared publication
Latest Publications
- 2 July 2012
- Published by Wiley in Immunology
- Vol. 136 (4) , 448-458
Extracellular ATP‐stimulated macrophages produce macrophage inflammatory protein‐2 which is important for neutrophil migration
Summary: Macrophages are the major source of the chemokines macrophage inflammatory protein‐2 (MIP‐2) and keratinocyte‐derived chemokine (KC), which play a major role in neutrophil migration to sites of inflammation. Although extracellular ATP from inflammatory tissues induces several immune responses in macrophages, it is unclear whether ATP‐stimulated macrophages affect neutrophil migration. Therefore, the aim of the present study was to investigate the role of ATP‐induced MIP‐2 production by macrophages. When ATP was injected intraperitoneally into mice, the number of neutrophils within the peritoneal cavity markedly increased, along with the levels of MIP‐2 and KC in the peritoneal lavage fluid. Consistent with this, ATP induced MIP‐2 production, but not that of KC, by peritoneal exudate macrophages (PEMs)in vitro.This occurred via interactions with the P2X7receptor and P2Y2receptor. Furthermore, treatment of PEMs with ATP led to the production of reactive oxygen species. The ATP‐induced MIP‐2 production was inhibited by treatment with the antioxidantN‐acetyl‐l‐cysteine. Also, MIP‐2 production was inhibited by pre‐incubating PEMs with inhibitors of extracellular signal‐regulated kinase 1/2 or p38 mitogen‐activated protein kinase. The MIP‐2 neutralization reduced the increase in neutrophil numbers observed in ATP‐treated mice. Taken together, these results suggest that increased production of reactive oxygen species by ATP‐stimulated macrophages activates the signalling pathways that promote MIP‐2 production which, in turn, induces neutrophil migration.
- 2 July 2012
- Published by Wiley in Immunology
- Vol. 136 (4) , 448-458
Extracellular ATP‐stimulated macrophages produce macrophage inflammatory protein‐2 which is important for neutrophil migration
Summary: Macrophages are the major source of the chemokines macrophage inflammatory protein‐2 (MIP‐2) and keratinocyte‐derived chemokine (KC), which play a major role in neutrophil migration to sites of inflammation. Although extracellular ATP from inflammatory tissues induces several immune responses in macrophages, it is unclear whether ATP‐stimulated macrophages affect neutrophil migration. Therefore, the aim of the present study was to investigate the role of ATP‐induced MIP‐2 production by macrophages. When ATP was injected intraperitoneally into mice, the number of neutrophils within the peritoneal cavity markedly increased, along with the levels of MIP‐2 and KC in the peritoneal lavage fluid. Consistent with this, ATP induced MIP‐2 production, but not that of KC, by peritoneal exudate macrophages (PEMs)in vitro.This occurred via interactions with the P2X7receptor and P2Y2receptor. Furthermore, treatment of PEMs with ATP led to the production of reactive oxygen species. The ATP‐induced MIP‐2 production was inhibited by treatment with the antioxidantN‐acetyl‐l‐cysteine. Also, MIP‐2 production was inhibited by pre‐incubating PEMs with inhibitors of extracellular signal‐regulated kinase 1/2 or p38 mitogen‐activated protein kinase. The MIP‐2 neutralization reduced the increase in neutrophil numbers observed in ATP‐treated mice. Taken together, these results suggest that increased production of reactive oxygen species by ATP‐stimulated macrophages activates the signalling pathways that promote MIP‐2 production which, in turn, induces neutrophil migration.
- Open Access
- 1 July 2000
- Published by Wiley in European Journal of Immunology
- Vol. 30 (7) , 1919-1928
Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide
It has been established that α‐galactosylceramide (α‐GalCer), a glycolipid, is recognized by natural killer T (NKT) cells together with the monomorphic MHC‐like antigen, CD1d, in mice and humans. In this study, we examined how NKT cells are modulated by in vivo administration of α‐GalCer in mice. When 2 μg (or more)/mouse of α‐GalCer was injected i.p., the majority of NKT cells disappeared in the liver and spleen, possibly undergoing apoptosis, on day 1. At this time, NKT cytotoxicity seen in liver lymphocytes also disappeared. In parallel with this numerical and functional change of NKT cells, there was always concomitant hepatocyte damage, as shown by histology and elevated levels of transaminases. Subsequently, the number and function of NKT cells continued to increase from day 3 to day 7. The response seen in hepatic (and splenic) NKT cells did not occur in thymic NKT cells. All these phenomena induced in the liver did not appear in NKT‐deficient mice such as β2‐microglobulin–/– and CD1d–/– mice. These results shed further light on the in vivo interaction between NKT cells and α‐GalCer in mice.
- 1 July 2000
- Published by Wiley in European Journal of Immunology
- Vol. 30 (7) , 1919-1928
Open AccessActivation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide
It has been established that α‐galactosylceramide (α‐GalCer), a glycolipid, is recognized by natural killer T (NKT) cells together with the monomorphic MHC‐like antigen, CD1d, in mice and humans. In this study, we examined how NKT cells are modulated by in vivo administration of α‐GalCer in mice. When 2 μg (or more)/mouse of α‐GalCer was injected i.p., the majority of NKT cells disappeared in the liver and spleen, possibly undergoing apoptosis, on day 1. At this time, NKT cytotoxicity seen in liver lymphocytes also disappeared. In parallel with this numerical and functional change of NKT cells, there was always concomitant hepatocyte damage, as shown by histology and elevated levels of transaminases. Subsequently, the number and function of NKT cells continued to increase from day 3 to day 7. The response seen in hepatic (and splenic) NKT cells did not occur in thymic NKT cells. All these phenomena induced in the liver did not appear in NKT‐deficient mice such as β2‐microglobulin–/– and CD1d–/– mice. These results shed further light on the in vivo interaction between NKT cells and α‐GalCer in mice.